Evonik, DE000EVNK013

Evonik stock: 22.08 euros as BASF focus remains central

Published on 11/17/2026 at 17:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Evonik stock remains in focus after Jefferies cut its rating to Hold from Buy. Fourth-quarter results and 2027 guidance are due on March 4, 2027.

Key points for investors

  • Jefferies cut Evonik to Hold from Buy and lowered its 2027 EBITDA forecast by 9 percent.
  • Evonik's fourth-quarter results and 2027 guidance are scheduled for March 4, 2027.
  • The BASF situation remains an important factor in the group's valuation outlook.
Evonik, DE000EVNK013, Illustration mit AI erstellt.

Evonik stock traded at 22.08 euros on Lang & Schwarz at 17:39 CET on Tuesday, November 17, 2026, unchanged from the Xetra close of Tuesday, November 17. The quote was 5.44 percent above the 20.94 euros recorded in the November 12 article.

Jefferies takes a more cautious view

In a report published on November 11, Investing.com said Jefferies had cut Evonik to Hold from Buy. The brokerage also reduced its 2027 EBITDA forecast by 9 percent to below 2 billion euros as support from Middle East supply disruptions fades.

Jefferies raised its price target to 21 euros from 20 euros. It said near-term share-price performance could depend more on potential engagement with BASF than on standalone fundamentals.

Results remain the next milestone

Evonik's fourth-quarter results and 2027 guidance are scheduled for March 4, 2027. Investors will be watching whether pricing, volumes and efficiency measures can offset weaker support from supply disruptions.

Jefferies said Evonik's EBITDA was up 14 percent year to date, with Advanced Technologies up 25 percent while Custom Solutions was approximately flat. The brokerage expects a 2029 return on capital employed of 8.9 percent, below Evonik's 11 percent target.

Evonik Industries AG

  • ISIN: DE000EVNK013
  • Ticker: EVK.DE
  • Lang & Schwarz quote: 22.08 euros on November 17, 2026, at 17:39 CET
  • Xetra close: 22.08 euros on November 17, 2026

German equities remain in focus for investors following market developments. Current market reports provide the broader market setting.

More news and analyses on Evonik stock

Disclaimer...
en | DE000EVNK013 | EVONIK | boerse | 70527959 | bgmi